Literature DB >> 22092583

Surgical-site infections and routes of bacterial transfer: which ones are most plausible?

Omar A Ibrahimi1, Victoria Sharon, Daniel B Eisen.   

Abstract

BACKGROUND: Surgical-site infections (SSIs) are an unfortunate consequence of cutaneous surgery. Their incidence can be a significant problem for patients and surgeons. Most SSIs are presumed to originate from the patient and operating room staff.
OBJECTIVES: To review the potential routes of iatrogenic bacterial transfer during cutaneous surgery.
METHODS: A review of the medical literature.
CONCLUSIONS: Potential routes of bacterial transfer during surgery include respiratory droplets and nuclei, skin scales carried on air currents, direct contact with the surgical team's skin, and contaminated fomites. The route with the most significant potential for iatrogenic bacterial transfer is direct physical contact. Strategies that minimize contact with infected fomites and with the surgical team would probably have the best chances of reducing the incidence of SSIs.
© 2011 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22092583     DOI: 10.1111/j.1524-4725.2011.02183.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

1.  Increased incidence of chalazion associated with face mask wear during the COVID-19 pandemic.

Authors:  Rona Z Silkiss; Michael K Paap; Shoaib Ugradar
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-09

2.  Incidence, risk factors and outcomes of surgical site infections among patients admitted to Jimma Medical Center, South West Ethiopia: Prospective cohort study.

Authors:  Gemedo Misha; Legese Chelkeba; Tsegaye Melaku
Journal:  Ann Med Surg (Lond)       Date:  2021-03-29

3.  Assessment of the Effect of Wearing a Surgical Face Mask on Tear Film in Normal Eye Subjects.

Authors:  Mana A Alanazi; Gamal A El-Hiti; Rashid Al-Tamimi; Abdullah M Bawazir; Essam S Almutleb; Raied Fagehi; Saud A Alanazi; Ali M Masmali
Journal:  J Ophthalmol       Date:  2022-08-16       Impact factor: 1.974

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.